Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Legislative Action Center"

Advocate at Home During the August Recess

From the College  |  August 5, 2021

With lawmakers home for the summer recess, you have the opportunity to meet with them in their local offices and help them understand how key legislation affects patients and healthcare providers. The ACR offers tools, resources and more to help.

Advocacy Begins at Home

Chris Morris, MD  |  April 3, 2019

As the frustration with changes in healthcare grows, and after speaking with the vociferous advocates who are part of the ACR, you have decided that you need to become involved in advocacy for your patients, your practice and your profession. Welcome to the fold. How to Help from Home Many people indicate they aren’t more…

Write Your Letter to the Editor: The ACR Makes It Easy

From the College  |  April 4, 2018

Elected officials and government entities make decisions every day that directly affect your practice and ability to treat patients. Although the ACR continues to be your eyes and ears in Washington, D.C., often the most effective agents of change are citizens, like you, who get involved in the legislative process. It’s easy to be an…

Rheumatologists Urged to Engage in Advocacy

Mary Beth Nierengarten  |  October 31, 2016

“Doctors must be politically active or they will surrender the control of healthcare to others,” says Tim Hutchinson, former U.S. Senator from Arkansas (Republican), emphasizing the need for rheumatologists to become involved in advocacy given the particularly challenging environment caused by partisan polarization and gridlock in Washington—which is expected to continue regardless of the upcoming…

The ACR Continues Fight to Block Medicare Part B Demo Project: Rule Expected in Fall 2016

Kathy Holliman  |  August 4, 2016

The ACR will seek Congressional action if the Medicare Part B demonstration project proposed by the Centers for Medicare & Medicaid Services (CMS) is not significantly altered by the agency. Today, Medicare Part B generally pays physicians and hospital outpatient departments the average sales price of a drug, plus a 6% add-on, minus reductions required…

The ACR’s Legislative Action Center Ensures Rheumatology’s Voice Is Heard in Washington

From the College  |  January 19, 2016

It’s easier than ever to become a part of advocacy efforts at the federal and state levels. Visit the ACR’s new Legislative Action Center to send a personalized message to your lawmakers, asking them to give patients access to treatments, to provide funding for biomedical research and to prevent insurer practices from interfering with treatment…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences